Click here to view Full Prescribing Information
(Kit for the Preparation of Technetium Tc 99m Mertiatide Injection)
Indications and Usage
Kit for the Preparation of Technetium Tc 99m Mertiatide Injection, after radiolabeling with technetium-99m, is indicated for use in the diagnosis of congenital and acquired renal abnormalities, renal failure, urinary tract obstruction, and calculi in adults and pediatric patients aged 30 days and older. The product is a diagnostic aid in providing renal function, split function, renal angiograms, and renogram curves for whole kidney and renal cortex.
DISCLAIMER:
This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient. For full Prescribing Information including indications, contraindications, warnings, precautions and adverse events, please see the appropriate product labeling.
Product Overview
Product Name
Kit for the Preparation of Technetium Tc 99m Mertiatide Injection
Description
Kit for the Preparation of Technetium Tc 99m Mertiatide Injection contains 1 mg betiatide supplied as a white lyophilized powder packaged in 10 mL glass multiple-dose vials. Radiolabeling with sodium pertechnetate Tc 99m injection provides a clear, colorless solution containing up to 3,700 MBq (100 mCi) technetium Tc 99m mertiatide in approximately 10 mL volume at calibration time.
Contraindications
None
Warnings and Precautions
Radiation risks: Ensure safe handling to minimize radiation exposure to patients and healthcare providers.
Adverse Reactions
Reported adverse reactions are tachycardia, nausea, vomiting, shaking, chills, fever, seizure, wheezing, dyspnea, itching, rash, and elevation in blood pressure.
Product Insert
Click here to view Product Insert.
Safety Data Sheet
Click here to view SDS